The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase ib-II study of dabrafenib, trametinib, cetuximab plus irinotecan in patients with BRAF mutant metastatic colorectal cancer: Subgroup analysis and biomarker identification.
 
Yungchang Chen
No Relationships to Disclose
 
Hai Hu
No Relationships to Disclose
 
Bo Song
No Relationships to Disclose
 
Jin Shang
No Relationships to Disclose
 
Yuxin Man
No Relationships to Disclose
 
Qian Guo
No Relationships to Disclose
 
Hongfan Yuan
No Relationships to Disclose
 
Yuanyi Rui
No Relationships to Disclose
 
Zijian Deng
No Relationships to Disclose
 
Tao Pan
No Relationships to Disclose
 
Bo Yi
No Relationships to Disclose
 
Zhixuan Zhang
No Relationships to Disclose
 
Ping Chen
No Relationships to Disclose
 
Jin Lu
No Relationships to Disclose
 
Deyuan Zhong
No Relationships to Disclose
 
Tongyu Lin
No Relationships to Disclose